Free Trial

Bruker (BRKR) 10K Form and Latest SEC Filings 2026

Bruker logo
$38.01 +1.62 (+4.45%)
Closing price 04:00 PM Eastern
Extended Trading
$38.44 +0.43 (+1.12%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Bruker SEC Filings & Recent Activity

Bruker (NASDAQ:BRKR) has submitted 319+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Bruker's financial statements. The most recent filing was a Form 8-K submitted on April 28, 2026.

Form 4
BRUKER CORP Reports Ownership Change on Apr. 16, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Bruker Files Current Report on Apr. 28, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Bruker Files Quarterly Report on Nov. 5, 2025

The 10-Q contains Bruker's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Bruker SEC Filing History

Browse Bruker's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
04/28/2026 3:16 PM
Bruker (1109354) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2026 3:15 PM
Bruker (1109354) Issuer
Munch Mark (1544635) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2026 3:08 PM
Bruker (1109354) Subject
Munch Mark (1544635) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2026 3:17 PM
Bruker (1109354) Filer
Form DEF 14A
04/10/2026 3:20 PM
Bruker (1109354) Filer
Form DEFA14A
04/10/2026 3:24 PM
Bruker (1109354) Filer
Form ARS
04/10/2026 3:06 PM
Bernard Thierry (1815490) Reporting
Bruker (1109354) Issuer
Form 3
Initial statement of beneficial ownership of securities  
04/01/2026 6:00 AM
Bruker (1109354) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2026 3:44 PM
Bruker (1109354) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/16/2026 3:15 PM
Bruker (1109354) Issuer
Munch Mark (1544635) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 3:19 PM
Bruker (1109354) Subject
Munch Mark (1544635) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2026 10:45 AM
Bruker (1109354) Subject
ORBIS INVESTMENT MANAGEMENT LTD (940594) Filed by
Form SCHEDULE 13G/A
02/27/2026 4:09 PM
Bruker (1109354) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2026 4:10 PM
Bruker (1109354) Filer
Form S-8 POS
02/20/2026 3:38 PM
Bruker (1109354) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2026 3:38 PM
Bruker (1109354) Issuer
FRANCIS LAURA (1218802) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 3:15 PM
Anderson Bonnie H (1588970) Reporting
Bruker (1109354) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 3:15 PM
Bruker (1109354) Issuer
Munch Mark (1544635) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 3:15 PM
Bruker (1109354) Issuer
Requardt Hermann Fritz (1651105) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 3:15 PM
Bruker (1109354) Issuer
Bures Thomas (1787029) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 3:15 PM
Bruker (1109354) Issuer
ROSENTHAL BOB (1203911) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 3:15 PM
Bruker (1109354) Issuer
Friend Cynthia M (1675108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 3:15 PM
Bruker (1109354) Issuer
PACKER RICHARD A (1237765) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 3:15 PM
Bruker (1109354) Issuer
Perkins Adelene Q (1375124) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 3:15 PM
Bruker (1109354) Issuer
LINTON WILLIAM A (1243154) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 3:15 PM
Bruker (1109354) Issuer
ORNELL JOHN A (1186875) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 3:15 PM
Bruker (1109354) Issuer
Phillips Jack (1784805) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 11:03 AM
Bruker (1109354) Subject
ORBIS INVESTMENT MANAGEMENT LTD (940594) Filed by
Form SCHEDULE 13G/A
02/17/2026 9:28 AM
Bruker (1109354) Subject
T. Rowe Price Investment Management, Inc. (1897612) Filed by
Form SCHEDULE 13G/A
02/12/2026 6:00 AM
Bruker (1109354) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2026 3:15 PM
Bruker (1109354) Issuer
Munch Mark (1544635) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2026 3:01 PM
Bruker (1109354) Subject
Munch Mark (1544635) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2026 3:15 PM
Bruker (1109354) Issuer
Munch Mark (1544635) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2026 3:07 PM
Bruker (1109354) Subject
Munch Mark (1544635) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2026 11:00 AM
Bruker (1109354) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2026 5:19 PM
Bruker (1109354) Issuer
Phillips Jack (1784805) Reporting
Form 3
Initial statement of beneficial ownership of securities  
01/06/2026 3:15 PM
Bruker (1109354) Issuer
Munch Mark (1544635) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2025 9:10 AM
Bruker (1109354) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2025 3:15 PM
Bruker (1109354) Issuer
PACKER RICHARD A (1237765) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2025 3:14 PM
Bruker (1109354) Subject
PACKER RICHARD A (1237765) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2025 11:53 AM
Bruker (1109354) Subject
ORBIS INVESTMENT MANAGEMENT LTD (940594) Filed by
Form SCHEDULE 13G
11/06/2025 3:10 PM
Bruker (1109354) Subject
ORNELL JOHN A (1186875) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2025 3:30 PM
Bruker (1109354) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2025 6:00 AM
Bruker (1109354) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2025 2:49 PM
Bruker (1109354) Subject
Form SCHEDULE 13G/A
09/12/2025 3:15 PM
Bruker (1109354) Issuer
Friend Cynthia M (1675108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2025 3:40 PM
Bruker (1109354) Filer
Form 8-A12B
09/05/2025 3:49 PM
Bruker (1109354) Filer
Form 424B5
09/04/2025 5:01 AM
Bruker (1109354) Subject
Form FWP
09/02/2025 3:45 PM
Bruker (1109354) Filer
Form 424B5
08/12/2025 3:15 PM
Bruker (1109354) Issuer
Herman Gerald N (1327294) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025 3:15 PM
Bruker (1109354) Issuer
LAUKIEN FRANK H (1133649) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025 3:15 PM
Bruker (1109354) Issuer
Munch Mark (1544635) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2025 6:00 AM
Bruker (1109354) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2025 7:00 AM
Bruker (1109354) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2025 3:34 PM
Bruker (1109354) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2025 7:00 AM
Bruker (1109354) Filer
Form DEFA14A
05/07/2025 6:00 AM
Bruker (1109354) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Bruker SEC Filings - Frequently Asked Questions

Bruker (BRKR) has submitted 319+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Bruker's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Bruker's financial statements page.

The most recent filing was a Form 8-K submitted on April 28, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:BRKR) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners